Detalhe da pesquisa
1.
Phase 1b Trial Evaluating Tolerability and Activity of Targeted Fibroblast Growth Factor Receptor Inhibition in Localized Upper Tract Urothelial Carcinoma.
J Urol
; : 101097JU0000000000003928, 2024 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38573872
2.
Front-line Treatment with Gemcitabine, Paclitaxel, and Doxorubicin for Patients With Unresectable or Metastatic Urothelial Cancer and Poor Renal Function: Final Results from a Phase II Study.
Urology
; 89: 83-9, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26723185